GSK exec joins Inspire
Former GlaxoSmithKline Assistant General Counsel for R&D Business Development Transactions Joseph Spagnardi joins Inspire as deputy general counsel, a newly created position. Spagnardi reports to Inspire General Counsel Barry Pea...
You may also be interested in...
Analysts agree that new Phase III data suggests the antibody-drug conjugate will be a new standard of care in third-line TNBC, with potential in earlier treatment lines and in several other tumor types.
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
Discusses KRAS G12C and the importance of biomarker testing in non-small cell lung cancer (NSCLC).